Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Dysregulation of blood sugar levels in type 2 diabetes mellitus can be managed with Dynaglim MV 2mg/500mg/0.3mg Tablet. It is recommended when diet, exercise, and a single medication fail to adequately control blood glucose levels.
Dynaglim MV 2mg/500mg/0.3mg Tablet is a combination drug used to manage type 2 diabetes. It contains three active components: 2 mg Glimepiride, 500 mg Metformin, and 0.3 mg Voglibose. Glimepiride stimulates insulin release, Metformin reduces liver glucose production and enhances insulin sensitivity, and Voglibose slows carbohydrate absorption in the intestines, helping to control blood glucose levels more effectively.
strip of 10 tablets
Dynamark Life Sciences Private Limited
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Dynaglim MV 2mg/500mg/0.3mg Tablet is usually taken with food to minimize gastrointestinal discomfort. Follow the dosage instructions provided by your healthcare professional carefully and do not exceed the advised dose.
Related Warnings
Alcohol consumption can increase the risk of hypoglycemia and may affect the efficacy of Dynaglim MV 2mg/500mg/0.3mg Tablet. It is advisable to limit alcohol intake and consult your doctor regarding acceptable levels of consumption.
Dynaglim MV 2mg/500mg/0.3mg Tablet is generally not recommended during pregnancy. If you are pregnant or planning to become pregnant, consult your doctor for safer alternative therapies for blood sugar management.
The safety of Dynaglim MV 2mg/500mg/0.3mg Tablet during breastfeeding is not well-established. If you are breastfeeding or planning to breastfeed, consult your doctor to determine if this medication is appropriate or if other treatments should be considered.
Dynaglim MV 2mg/500mg/0.3mg Tablet may cause low blood sugar or dizziness, which can impair your ability to drive or operate machinery. Exercise caution and avoid driving if you feel lightheaded or drowsy. Consult your doctor if you have concerns.
Dosage of Dynaglim MV 2mg/500mg/0.3mg Tablet may need adjustment in patients with kidney issues. Regular monitoring of renal function is advised. Inform your doctor of any kidney problems before starting this medication.
Liver function can influence the metabolism of Dynaglim MV 2mg/500mg/0.3mg Tablet. If you have liver problems, your doctor may need to adjust your dosage or monitor you more closely. Notify your doctor of any liver issues.
Q:Can I combine Dynaglim MV 2mg/500mg/0.3mg Tablet with another diabetic prescription?
A:Yes, but consult your doctor to manage potential interactions and adjust dosages as necessary.
Q:What should I do if I miss a dose?A:Take the missed dose as soon as you remember. If the next dose is near, skip the missed dose and continue with your regular schedule. Do not double the dose.
Q:Does Dynaglim MV 2mg/500mg/0.3mg Tablet promote weight gain?A:Weight gain is not commonly associated with this medication, though individual reactions can vary. Discuss any concerns with your doctor.
Q:How should I store Dynaglim MV 2mg/500mg/0.3mg Tablet?A:Store in a cool, dry place at room temperature. Keep out of reach of children.
Q:What should I do if I experience serious side effects?A:If you experience severe side effects, such as symptoms of lactic acidosis or a severe allergic reaction, seek medical attention immediately.
